ArticleAnalytical chemistry2026
Reducing Bias in Mass Cytometry Data through Corrections for Spillover and Nonspecific Binding.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Mass cytometry can facilitate the study of over 40 protein markers in single cells, making it an ideal technique to investigate complex biological systems. The use of antibodies tagged with metal isotopes as probes makes mass cytometry measurements susceptible to isotopic spillover. In this report, we introduce ccSpill, an instrument-specific matrix built from calibration curves of metal-labeled antibodies and solutions of pure metals that can be applied to single-cell data to remove spillover. ccSpill is unique to each lab, and each set of reporter antibodies and is compatible with isotype-based nonspecific binding (NSB) corrections. We demonstrate that combining ccSpill with NSB corrections is integral to the optimization of sample preparation procedures that involve challenging antibodies and that such a correction identifies and excludes cell artifacts in single-cell analyses. Furthermore, the combined correction demonstrated that low metal ion/antibody ratios are detrimental to capturing features at the edges of single-cell distributions, which are misassigned without a correction. Lastly, by applying the combined correction to phenotypic markers, the identification of cell types was highly enhanced. Combined corrections of spillover and NSB provide a gateway to use mass cytometry unequivocally to characterize rare cells (e.g., senescent), subtypes (e.g., endothelial), or treatment (e.g., rapamycin), which is highly needed in clinical and biomedical research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.